CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood in Pune
50+ booked in last 3 daysOverview
The CLL (Chronic Lymphocytic Leukemia) prognostication/risk stratification gene panel, performed on EDTA whole blood samples, is a diagnostic test used for assessing the prognosis and risk stratification of patients with CLL. This gene panel examines various genetic markers and mutations associated with CLL like TP53, NOTCH1, SF3B1, ATM, and other relevant genes. By analyzing these genetic markers, the panel helps in predicting disease progression, treatment response, and overall patient outcomes. The results of the panel aid healthcare professionals in determining the appropriate management strategies, including the selection of therapies and the frequency of follow-up evaluations. This CLL prognostication gene panel serves as a valuable tool in tailoring individualized treatment approaches and improving patient care for those diagnosed with CLL.
CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood Price in Pune
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood with a clear pricing structure
The price of CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood in Pune is ₹ 17,680
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.